首页 | 本学科首页   官方微博 | 高级检索  
     

西洛他唑治疗肢体动脉缺血性疾病的临床疗效观察
引用本文:吴庆华 唐小斌. 西洛他唑治疗肢体动脉缺血性疾病的临床疗效观察[J]. 心肺血管病杂志, 1997, 16(3): 211-214
作者姓名:吴庆华 唐小斌
摘    要:
我院自1992年11月至1995年2月采用随机双盲法应用抗血小板聚集新药西洛他唑与噻氯匹定对照治疗四肢慢性动脉闭塞缺血性疾病48例,实验结果表明西洛他叹治疗四肢动脉缺血性疾病总有效率为929%,可明显提高息肢血压指数(P<0.01)和降低血小板聚集率护<0.01),未发现严重毒副作用;提示西洛他唑是一种安全有效的治疗肢体缺血性疾病的新药。

关 键 词:肢体动脉缺血性疾病  西洛他唑  噻氯匹定

Clinical Effects of Cilestazol on Chronic Ischemia of Extremities
Wu Qinghua, Tang Xiaobin, Chen Zhong. Clinical Effects of Cilestazol on Chronic Ischemia of Extremities[J]. Journal of Cardiovascular and Pulmonary Diseases, 1997, 16(3): 211-214
Authors:Wu Qinghua   Tang Xiaobin   Chen Zhong
Abstract:
48 cases of chronic ischemia of extremities were treated with Cilostazol, a new drug, comparing toTiclopidine as antiplatelet therapy, by double- blind, randomized methods form Nov. 1992 to Feb 1995. The results showed that the total effect rate was 92. 9%; and the blood pressure index of the ischemic extremities was increased significantly (P< 0. 01); and the platelet aggregation was deceased (P<0. 01) with Cilotazol.
Keywords:Chronic ischamia of extremities  Cilostazol  Ticlopidine
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号